Addressing Polypharmacy in Geriatric Care: Insights from Ghana

Polypharmacy, defined as the concurrent use of multiple medications, poses significant health risks, especially for older adults. In sub-Saharan Africa, where healthcare resources are limited, the issue of potentially inappropriate prescribing (PIP) becomes even more pressing. A recent study conducted in Tatale, Ghana, utilized a synthetic cohort to evaluate the prevalence of PIP among geriatric patients suffering from comorbid hypertension and Type 2 diabetes. This research sheds light on the critical need for improved medication management in older populations, which is essential for metabolic health and overall well-being. The study generated a synthetic cohort of 2,307 geriatric patients aged 60 and older, calibrated to reflect demographic data from the 2022 Ghana Demographic and Health Survey. The findings revealed a baseline polypharmacy rate of 58.29%, indicating that more than half of the patients were on multiple medications. Screening for potentially inappropriate medications using the STOPP criteria identified a staggering 76.00% prevalence of PIP, compared to 49.22% identified by the Beers criteria. This significant difference (McNemar's p < 0.001) underscores the importance of using sensitive screening tools to identify harmful prescribing practices. For individuals managing their health, particularly older adults or caregivers, these findings highlight the necessity of regular medication reviews. Patients should advocate for their health by discussing their medication regimens with healthcare providers, ensuring that all prescribed medications are necessary and appropriate. Reducing polypharmacy can lead to fewer adverse drug reactions, improved adherence to treatment, and better management of chronic conditions such as diabetes and hypertension. This research connects to several biomarkers relevant to metabolic health, including fasting glucose and insulin levels, which are critical for assessing diabetes management. The high prevalence of polypharmacy and PIP can exacerbate insulin resistance and other metabolic issues, making it vital for healthcare providers to monitor these biomarkers closely. Tools like the HOMA-IR calculator can help evaluate insulin sensitivity and guide necessary lifestyle or medication adjustments. In conclusion, the study emphasizes the urgent need for improved prescribing practices in geriatric care, particularly in resource-limited settings. By utilizing validated screening criteria and focusing on the health of older adults, healthcare systems can enhance medication safety and metabolic health outcomes. Patients and caregivers should remain proactive in their health management, ensuring that polypharmacy is minimized and that medications are used appropriately.